Siguen bajando las tasas de mortalidad por cáncer en EE. UU.
JUEVES, 27 de octubre de 2022 (HealthDay News) — Las estadísticas más recientes del Instituto Nacional del Cáncer (NCI) de EE. UU. muestran un declive continuo en el número de estadounidenses que mueren de cáncer, aunque ha habido poco cambio en el n…
Learn MoreU.S. Cancer Death Rates Continue to Decline
THURSDAY, Oct. 27, 2022 (HealthDay News) — The latest statistics from the U.S. National Cancer Institute (NCI) show a continuing decline in the number of Americans who die from cancer, although there’s been little change in the number of new cancer c…
Learn MoreTerry Bradshow, el famoso futbolista, describe su batalla contra dos tipos de cáncer
MARTES, 4 de octubre de 2022 (HealthDay News) — El miembro del Salón de la Fama del Fútbol Americano, Terry Bradshaw reveló el domingo que ha estado recibiendo tratamiento para dos tipos de cáncer en el último año.Bradshaw hizo sus declaraciones sobr…
Learn MoreFootball Great Terry Bradshaw Describes Battle Against Two Kinds of Cancer
TUESDAY, Oct. 4, 2022 (HealthDay News) — Football Hall of Famer Terry Bradshaw revealed Sunday that he has been treated for two different types of cancer in the past year. Bradshaw talked about his health while co-hosting Fox NFL Sunday.“Last week on…
Learn MoreGemcitabine/Docetaxel Treats Nonmuscle-Invasive Bladder Cancer
FRIDAY, Aug. 19, 2022 (HealthDay News) — Gemcitabine plus docetaxel (Gem/Doce) may be an alternative for the treatment of high-risk non-muscle-invasive bladder cancer (NMIBC), according to a study published in the September issue of The Journal of Ur…
Learn MoreRisk Stratification Examined for High-Grade Ta Bladder Tumors
TUESDAY, Aug. 2, 2022 (HealthDay News) — For patients treated with adequate bacillus Calmette-Guérin (BCG), all high-grade (HG) Ta tumors have similar rates of BCG unresponsiveness and progression, regardless of prognostic risk factors, according t…
Learn More